SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.07-0.1%Nov 17 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BigKNY3 who wrote (7303)3/26/1999 7:39:00 PM
From: BigKNY3  Read Replies (1) of 9523
 
IMS Health Reports Celebrex U.S. Prescriptions Dispensed Reach 299,571 in Third Week of March

LONDON--(BW HealthWire)--March 26, 1999--IMS HEALTH (NYSE:RX - news) today reported that for the week ending March 19, total Celebrex prescriptions dispensed in the U.S. reached 299,571, up 7.3 percent from the previous week. The rate of mail order prescriptions rose as well, up 5.4 percent from the second week of March, to 16,128 prescriptions. IMS HEALTH's regular weekly prescription activity report covering the week ending March 19 becomes available on Monday, March 29. IMS HEALTH is the world's leading provider of information solutions to the pharmaceutical and healthcare industries.

In the ten weeks since its introduction in the U.S., a total of 1.5 million Celebrex prescriptions have been dispensed. The majority of weekly Celebrex prescriptions continues to be new prescriptions, which represented 82 percent of prescribing for the week ending March 19. The remaining 18 percent, or 53,620 Celebrex prescriptions, were refills.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext